Tag: Drug
French Study Warns of Little-known Side Effect from Mesothelioma Drug, According to Surviving Mesothelioma
Raleigh, NC (PRWEB) January 05, 2015 Researchers in Perigueux, France are warning fellow cancer doctors to be on the look-out for a little-known side effect of the popular mesothelioma drug pemetrexed. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now. Scientists at Perigueux Hospital in Perigueux, […]
Neuropathic Pain Drug Market (Painful Diabetic Neuropathy, Postherpetic and Trigeminal Neuralgia) Forecast to 2022 in New Report Available at MarketOptimizer.org
Dallas, Texas (PRWEB) September 26, 2014 With seven promising neuropathic pain (NP) treatments expected to be launched in the coming years, the NP therapeutics market value – covering painful diabetic neuropathy, postherpetic neuralgia and trigeminal neuralgia – is forecast to increase from $ 2.58 billion in 2012 to $ 3.53 billion by 2022, at a […]
Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com
London, UK (PRWEB) August 22, 2014 The improved access to antiretroviral drugs and treatments in the recent past, specifically in the developing world, has led to the decline in the rate of HIV infection and the number of deaths due to AIDS globally. However, despite the fact that HIV infection rates are declining, the number […]
Byetta Lawsuit News: Bernstein Liebhard LLP Notes British Columbia’s Recent Decision to Discontinue Incretin Mimetic Drug Coverage from PharmaCare Program
New York, NY (PRWEB) August 15, 2014 Healthcare regulators in British Columbia have stopped patient coverage of a diabetes drug now involved in hundreds of Byetta lawsuits (http://www.byettalawsuit.com/) as well as several other medications, Bernstein Liebhard LLP reports. According to a notice posted earlier this month on Merck Canada’s website, the British Columbia Medical […]